- Home
- OTLK vs VIRC Comparison
OTLK vs VIRC Comparison
Compare OTLK & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OTLK | VIRC |
|---|---|---|
| Founded | 2010 | 1950 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 114.0M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | OTLK | VIRC |
|---|---|---|
| Price | $0.56 | $6.50 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.83 | N/A |
| AVG Volume (30 Days) | ★ 11.3M | 66.5K |
| Earning Date | 02-13-2026 | 12-08-2025 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $1,413,535.00 | ★ $201,942,000.00 |
| Revenue This Year | $2,048.59 | $0.81 |
| Revenue Next Year | $142.11 | $4.56 |
| P/E Ratio | ★ N/A | $26.93 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $6.01 |
| 52 Week High | $3.39 | $12.09 |
Technical Indicators
Market Signals| Indicator | OTLK | VIRC |
|---|---|---|
| Relative Strength Index (RSI) | 23.99 | 45.37 |
| Support Level | $0.50 | $6.20 |
| Resistance Level | $2.03 | $6.57 |
| Average True Range (ATR) | 0.22 | 0.18 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 3.27 | 58.82 |
Price Performance
Historical ComparisonAbout OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.